Fatty liver disease is becoming a widespread condition, affecting nearly 25% of adults globally.1 In other words, about one in every four people around you likely have a fatty liver without even realizing it. As the name implies, fatty liver is characterized by an abnormal buildup of fat in your liver cells, which triggers inflammation,… Read More: Developing a Fatty Liver Increases Your Risk of Mortality »
Two key studies have identified the role melatonin plays in reducing the risk of a positive test for COVID-191 and lowering the incidence of severe symptoms.2 Melatonin was first discovered in 1958 by Dr. Aaron Lerner, a dermatologist, who was able to isolate it from the pineal gland in a cow.3 Scientists began studying melatonin… Read More: Melatonin Affects Thrombosis, Sepsis and COVID Mortality Rate »
FDA Approves Nulibry (fosdenopterin) to Reduce the Risk of Mortality in Patients with Molybdenum Cofactor Deficiency (MoCD) Type A PALO ALTO, February 28, 2021 – BridgeBio Pharma, Inc. (Nasdaq: BBIO) (BridgeBio) and affiliate Origin Biosciences, Inc. (Origin) today announced the U.S. Food and Drug Administration (FDA) has approved Nulibry (fosdenopterin) for Injection as the first… Read More: FDA Approves Nulibry (fosdenopterin) to Reduce the Risk of Mortality… »
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported. The news comes from Cancer Statistics, 2020, the latest edition of the American Cancer Society’s annual report on cancer rates and trends. The steady 26-year decline in… Read More: Cancer mortality continues steady decline, driven by progress against lung… »